Fed’s Powell opens door to potential rate cuts at Jackson Hole
Investing.com - Cantor Fitzgerald has reiterated its Overweight rating and $11.00 price target on Codexis, Inc. (NASDAQ:CDXS), maintaining its positive outlook on the enzyme engineering company. The target represents significant upside potential, with analyst targets ranging from $3 to $11, according to InvestingPro data.
The research firm noted that Codexis strengthened its balance sheet in the most recent quarter, providing funding for building costs. This financial reinforcement comes as the company continues to develop its operations. InvestingPro data shows the company maintains a healthy current ratio of 5.82, with liquid assets well exceeding short-term obligations.
Cantor Fitzgerald highlighted that the company’s ligase strategy "has taken off" and is expected to serve as an important source of cash for Codexis moving forward.
The firm updated its financial model following Codexis’s quarterly results and made minor adjustments to its income statement projections based on guidance provided by the company.
Despite these updates to the financial model, Cantor Fitzgerald made no changes to its 12-month price target of $11 for Codexis stock, keeping it well above the company’s current trading price.
In other recent news, Codexis Inc. reported its second-quarter 2025 earnings, showcasing a notable earnings per share (EPS) of -$0.16. This figure exceeded analyst projections, which anticipated an EPS of -$0.19. Alongside this earnings surprise, Codexis experienced a significant revenue boost, reporting $15.3 million compared to $8 million in the same quarter the previous year. These recent developments highlight a positive financial trajectory for the company. The earnings results were a 15.79% positive surprise, indicating stronger-than-expected performance. Although the stock price movement is not discussed here, the financial results alone provide valuable insights for investors. Analyst firms have not been mentioned for upgrades or downgrades in this context. Investors may find these developments noteworthy as they consider their investment strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.